Abstract:
The present invention relates to a novel process for the preparation of (R)-N-(5-(5-ethyl-1,2,4-oxadiazol-3-yl)-2,3-dihydro-1H-inden-1-yl)-1-methyl-1H-pyrazole-4-carboxamide, which is referred to as Aficamten and represented by the following structural formulae,
Formula-
